{"name":"Domain Associates","permalink":"domain-associates","crunchbase_url":"http://www.crunchbase.com/financial-organization/domain-associates","homepage_url":"http://www.domainvc.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"609-683-5656","description":"","email_address":"","number_of_employees":null,"founded_year":1985,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Thu Jan 01 04:59:18 UTC 2009","updated_at":"Thu Jun 04 07:28:49 UTC 2009","overview":"<p>Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.</p>\n\n<p>Domainâ€™s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics.  The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies.  The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.</p>","image":{"available_sizes":[[[150,72],"assets/images/resized/0003/2807/32807v1-max-150x150.png"],[[250,121],"assets/images/resized/0003/2807/32807v1-max-250x250.png"],[[264,128],"assets/images/resized/0003/2807/32807v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"East Coast Office","address1":"One Palmer Square","address2":"Suite 515","zip_code":"08542","city":"Princeton","state_code":"NJ","country_code":"USA","latitude":40.3493186,"longitude":-74.6611033}],"relationships":[{"is_past":false,"title":"Principal","person":{"first_name":"Todd","last_name":"C. Brady","permalink":"todd-c-brady","image":{"available_sizes":[[[117,142],"assets/images/resized/0004/6618/46618v1-max-150x150.jpg"],[[117,142],"assets/images/resized/0004/6618/46618v1-max-250x250.jpg"],[[117,142],"assets/images/resized/0004/6618/46618v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Debra","last_name":"K. Liebert","permalink":"debra-k-liebert","image":{"available_sizes":[[[117,142],"assets/images/resized/0004/6620/46620v1-max-150x150.jpg"],[[117,142],"assets/images/resized/0004/6620/46620v1-max-250x250.jpg"],[[117,142],"assets/images/resized/0004/6620/46620v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Kim","last_name":"P. Kamdar","permalink":"kim-p-kamdar","image":{"available_sizes":[[[116,141],"assets/images/resized/0004/6619/46619v1-max-150x150.jpg"],[[116,141],"assets/images/resized/0004/6619/46619v1-max-250x250.jpg"],[[116,141],"assets/images/resized/0004/6619/46619v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"James","last_name":"Blair","permalink":"james-blair","image":null}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Neuron_Systems_Raises_First_Round","source_description":"Equity Help Desk","raised_amount":8960000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":8,"company":{"name":"Neuron Systems","permalink":"neuron-systems","image":{"available_sizes":[[[150,36],"assets/images/resized/0004/1194/41194v1-max-150x150.png"],[[250,61],"assets/images/resized/0004/1194/41194v1-max-250x250.png"],[[264,65],"assets/images/resized/0004/1194/41194v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.pehub.com/?p=36872","source_description":"Cell Biosciences Raises $10 Million","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":10,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.biparsciences.com/000019.html?n=28","source_description":"BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":2,"funded_day":26,"company":{"name":"BiPar Sciences","permalink":"bipar-sciences","image":{"available_sizes":[[[140,62],"assets/images/resized/0004/2189/42189v1-max-150x150.png"],[[140,62],"assets/images/resized/0004/2189/42189v1-max-250x250.png"],[[140,62],"assets/images/resized/0004/2189/42189v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.biparsciences.com/000019.html?n=35","source_description":"BiPar Sciences Raises $20 Million to Advance Clinical Programs","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":12,"company":{"name":"BiPar Sciences","permalink":"bipar-sciences","image":{"available_sizes":[[[140,62],"assets/images/resized/0004/2189/42189v1-max-150x150.png"],[[140,62],"assets/images/resized/0004/2189/42189v1-max-250x250.png"],[[140,62],"assets/images/resized/0004/2189/42189v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.esperion.com/modules/news/article.php?storyid=1","source_description":"Esperion Therapeutics Completes $22.75M Series A Financing","raised_amount":22750000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":1,"company":{"name":"Esperion Therapeutics","permalink":"esperion-therapeutics","image":{"available_sizes":[[[121,40],"assets/images/resized/0004/6610/46610v1-max-150x150.png"],[[121,40],"assets/images/resized/0004/6610/46610v1-max-250x250.png"],[[121,40],"assets/images/resized/0004/6610/46610v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Capital Funding Report","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":9,"company":{"name":"GenVault","permalink":"genvault","image":{"available_sizes":[[[124,40],"assets/images/resized/0004/6879/46879v1-max-150x150.png"],[[124,40],"assets/images/resized/0004/6879/46879v1-max-250x250.png"],[[124,40],"assets/images/resized/0004/6879/46879v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/clovis-oncology-inc-series-a-145m/","source_description":"Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development","raised_amount":145000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":26,"company":{"name":"Clovis Oncology","permalink":"clovis-oncology","image":{"available_sizes":[[[150,39],"assets/images/resized/0017/8043/178043v1-max-150x150.png"],[[250,65],"assets/images/resized/0017/8043/178043v1-max-250x250.png"],[[262,69],"assets/images/resized/0017/8043/178043v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.equityhelpdesk.com/PrivateEquity/Glaukos_Adds_35_Million","source_description":"Glaukos Adds $35 Million","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":29,"company":{"name":"Glaukos","permalink":"glaukos","image":{"available_sizes":[[[135,22],"assets/images/resized/0005/0243/50243v1-max-150x150.png"],[[135,22],"assets/images/resized/0005/0243/50243v1-max-250x250.png"],[[135,22],"assets/images/resized/0005/0243/50243v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/marinus-pharmaceuticals-inc-series-b-20m/","source_description":"Marinus Pharmaceuticals, Inc.: Series B $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":3,"company":{"name":"Marinus Pharmaceuticals","permalink":"marinus-pharmaceuticals","image":{"available_sizes":[[[150,51],"assets/images/resized/0005/0613/50613v1-max-150x150.png"],[[250,85],"assets/images/resized/0005/0613/50613v1-max-250x250.png"],[[285,97],"assets/images/resized/0005/0613/50613v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.nuontherapeutics.com/company/pr_2007-04-28.html","source_description":"Nuon Therapeutics, Inc. Completes $27 Million Series B Financing","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":28,"company":{"name":"Nuon Therapeutics","permalink":"nuon-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/1236/51236v1-max-150x150.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-250x250.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.basmedical.com/investor20071220.html","source_description":"Corthera Closes $23 Million Financing Round","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":20,"company":{"name":"Corthera","permalink":"corthera","image":{"available_sizes":[[[150,41],"assets/images/resized/0005/2839/52839v1-max-150x150.jpg"],[[229,64],"assets/images/resized/0005/2839/52839v1-max-250x250.jpg"],[[229,64],"assets/images/resized/0005/2839/52839v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/oraya-garners-42m-third-venture-round/2009-07-20?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Oraya garners $42M in third venture round","raised_amount":42000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":20,"company":{"name":"Oraya Therapeutics","permalink":"oraya-therapeutics","image":{"available_sizes":[[[150,97],"assets/images/resized/0005/2832/52832v1-max-150x150.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-250x250.jpg"],[[172,112],"assets/images/resized/0005/2832/52832v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/04/16/diobex-a-metabolic-disease-treatment-co-raises-24m/","source_description":"DiObex, a metabolic disease treatment co., raises $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":16,"company":{"name":"DiObex","permalink":"diobex","image":{"available_sizes":[[[150,39],"assets/images/resized/0005/9950/59950v1-max-150x150.jpg"],[[163,43],"assets/images/resized/0005/9950/59950v1-max-250x250.jpg"],[[163,43],"assets/images/resized/0005/9950/59950v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.sec.gov/Archives/edgar/data/1375151/000137515109000006/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":35957968,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/alimera-sciences-inc-series-c-5m/","source_description":"Alimera Sciences, Inc.: Series C $5M","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":1,"company":{"name":"Alimera Sciences","permalink":"alimera-sciences","image":{"available_sizes":[[[73,40],"assets/images/resized/0004/9636/49636v1-max-150x150.png"],[[73,40],"assets/images/resized/0004/9636/49636v1-max-250x250.png"],[[73,40],"assets/images/resized/0004/9636/49636v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/altair-therapeutics-inc-series-b-17m/","source_description":"Altair Therapeutics, Inc.: Series B $17M","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":2,"company":{"name":"Altair Therapeutics","permalink":"altair-therapeutics","image":{"available_sizes":[[[150,63],"assets/images/resized/0006/5844/65844v1-max-150x150.png"],[[238,100],"assets/images/resized/0006/5844/65844v1-max-250x250.png"],[[238,100],"assets/images/resized/0006/5844/65844v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://sanfrancisco.bizjournals.com/prnewswire/press_releases/California/2009/11/12/PH09784","source_description":"Microchip Biotechnologies Raises $18.1M in Series B Financing","raised_amount":18100000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":12,"company":{"name":"Microchip Biotechnologies","permalink":"microchip-biotechnologies","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/6036/66036v1-max-150x150.jpg"],[[196,82],"assets/images/resized/0006/6036/66036v1-max-250x250.jpg"],[[196,82],"assets/images/resized/0006/6036/66036v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.bio-medicine.org/biology-technology-1/Cell-Biosciences-Announces-New-Leadership-6227-2/","source_description":"Bio-Medicine","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":1,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.apnexmedical.com/","source_description":"Apnex Medical, Inc. Raises Additional $14 Million","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":2,"company":{"name":"Apnex Medical","permalink":"apnex-medical","image":{"available_sizes":[[[150,73],"assets/images/resized/0006/8533/68533v1-max-150x150.png"],[[226,111],"assets/images/resized/0006/8533/68533v1-max-250x250.png"],[[226,111],"assets/images/resized/0006/8533/68533v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020091217e5ch000jh&r=Rss&s=DJFVW","source_description":"Regado Biosciences Stays Patient, Looks To Europe With New $40M  ","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":17,"company":{"name":"Regado Biosciences","permalink":"regado-biosciences","image":{"available_sizes":[[[150,23],"assets/images/resized/0007/0256/70256v1-max-150x150.jpg"],[[250,39],"assets/images/resized/0007/0256/70256v1-max-250x250.jpg"],[[352,56],"assets/images/resized/0007/0256/70256v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2009/12/afferent-pharmaceuticals-closes-23m.html","source_description":"Afferent Pharmaceuticals Closes $23M Series A Financing Round","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Afferent Pharmaceuticals","permalink":"afferent-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0007/6112/76112v1-max-150x150.png"],[[250,71],"assets/images/resized/0007/6112/76112v1-max-250x250.png"],[[263,75],"assets/images/resized/0007/6112/76112v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://salesandmarketingnetwork.com/news_release.php?pipe=0000ac177000191&ID=2023127","source_description":"BioVascular Inc. Closes $10.87 Million Series C Financing","raised_amount":10870000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":7,"company":{"name":"BioVascular","permalink":"biovascular","image":{"available_sizes":[[[132,24],"assets/images/resized/0007/0433/70433v1-max-150x150.jpg"],[[132,24],"assets/images/resized/0007/0433/70433v1-max-250x250.jpg"],[[132,24],"assets/images/resized/0007/0433/70433v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.zogenix.com/index.php/news/zogenix-raises-18-million-in-preferred-stock-financing/","source_description":"Zogenix Raises $18 Million in Preferred Stock Financing","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":9,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.biospace.com/news_story.aspx?NewsEntityId=84511","source_description":"Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":31,"company":{"name":"Sonexa Therapeutics","permalink":"sonexa-therapeutics","image":null}}},{"funding_round":{"round_code":"a","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020100113e61d0002u&r=Rss&s=DJFVLS","source_description":"VentiRx Pharma Extends Series A To $51.6M  ","raised_amount":51600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":13,"company":{"name":"VentiRx Pharmaceuticals","permalink":"ventirx-pharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/3107/73107v1-max-150x150.png"],[[220,88],"assets/images/resized/0007/3107/73107v1-max-250x250.png"],[[220,88],"assets/images/resized/0007/3107/73107v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.altassets.com/private-equity-news/article/nz18111.html","source_description":"AltAssets","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":10,"company":{"name":"Carticept Medical","permalink":"carticept-medical","image":{"available_sizes":[[[150,53],"assets/images/resized/0007/9888/79888v1-max-150x150.jpg"],[[234,83],"assets/images/resized/0007/9888/79888v1-max-250x250.jpg"],[[234,83],"assets/images/resized/0007/9888/79888v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://genvault.com/press-releases/20070404_GenVault%20Corporation%20Raises.pdf","source_description":"GenVault Corporation Raises $18 Million of Financing","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":4,"company":{"name":"GenVault","permalink":"genvault","image":{"available_sizes":[[[124,40],"assets/images/resized/0004/6879/46879v1-max-150x150.png"],[[124,40],"assets/images/resized/0004/6879/46879v1-max-250x250.png"],[[124,40],"assets/images/resized/0004/6879/46879v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fasken.com/asmacure-closes-us9-million-series-a-financing/","source_description":"Asmacure closes US$9 million Series A financing","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":8,"company":{"name":"Asmacure LtÃ©e","permalink":"asmacure-lte","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/syndax-pharmaceuticals-inc-series-a-9m/","source_description":"Syndax Pharmaceuticals, Inc.: Series A $9M","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":16,"company":{"name":"Syndax Pharmaceuticals","permalink":"sndax-pharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0008/0485/80485v1-max-150x150.png"],[[206,83],"assets/images/resized/0008/0485/80485v1-max-250x250.png"],[[206,83],"assets/images/resized/0008/0485/80485v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/03/17/nuon-captures-6-05m-to-develop-treatments-for-autoimmune-disease/","source_description":"Nuon captures $6.05M to develop treatments for autoimmune disease","raised_amount":6050000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Nuon Therapeutics","permalink":"nuon-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/1236/51236v1-max-150x150.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-250x250.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.pr-inside.com/achaogen-completes-56-million-series-c-r1817734.htm","source_description":"Achaogen Completes $56 Million Series C Financing ","raised_amount":56000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":7,"company":{"name":"Achaogen","permalink":"achaogen","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/3158/83158v1-max-150x150.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-250x250.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/tragara-pharmaceuticals-inc-series-b-5m/","source_description":"Tragara Pharmaceuticals, Inc.: Series B $5M ","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":15,"company":{"name":"Tragara","permalink":"tragara","image":{"available_sizes":[[[150,41],"assets/images/resized/0004/8401/48401v1-max-150x150.jpg"],[[207,57],"assets/images/resized/0004/8401/48401v1-max-250x250.jpg"],[[207,57],"assets/images/resized/0004/8401/48401v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.zogenix.com/index.php/news/zogenix-inc-raises-60-million-in-series-a-venture-financing-names-board-of-directors/","source_description":"Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":28,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.achaogen.com/news/2/52","source_description":"Achaogen Closes Series B Financing","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":10,"company":{"name":"Achaogen","permalink":"achaogen","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/3158/83158v1-max-150x150.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-250x250.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.codatherapeutics.com/news-coda-financing.html","source_description":"CoDa Therapeutics Announces Series A Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":10,"company":{"name":"CoDa Therapeutics","permalink":"coda-therapeutics","image":{"available_sizes":[[[128,135],"assets/images/resized/0008/4437/84437v1-max-150x150.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-250x250.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/astute-medical-inc-series-b-265m/","source_description":"Astute Medical, Inc.: Series B $26.5M","raised_amount":26500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":12,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/sequent-medical-inc-series-b-156m/","source_description":"Sequent Medical, Inc.: Series B $15.6M","raised_amount":15600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":14,"company":{"name":"Sequent Medical","permalink":"sequent-medical","image":{"available_sizes":[[[150,31],"assets/images/resized/0008/7118/87118v1-max-150x150.png"],[[250,53],"assets/images/resized/0008/7118/87118v1-max-250x250.png"],[[450,95],"assets/images/resized/0008/7118/87118v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/veracyte-inc-series-b-28m/","source_description":"Veracyte, Inc.: Series B $28M","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":11,"company":{"name":"Veracyte","permalink":"veracyte","image":{"available_sizes":[[[150,41],"assets/images/resized/0009/0480/90480v1-max-150x150.png"],[[212,58],"assets/images/resized/0009/0480/90480v1-max-250x250.png"],[[212,58],"assets/images/resized/0009/0480/90480v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiveprime.com/index.php?option=com_content&task=view&id=27&Itemid=71","source_description":"Five Prime Therapeutics, Inc. Raises $45MM in Private Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":2,"funded_day":8,"company":{"name":"Five Prime Therapeutics","permalink":"five-prime-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0004/5633/45633v1-max-150x150.png"],[[185,68],"assets/images/resized/0004/5633/45633v1-max-250x250.png"],[[185,68],"assets/images/resized/0004/5633/45633v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.gabio.org/pr_details.aspx?subid=28&refid=13","source_description":"Alimera Sciences Secures $31.8 Million in Series B Financing","raised_amount":31800000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":30,"company":{"name":"Alimera Sciences","permalink":"alimera-sciences","image":{"available_sizes":[[[73,40],"assets/images/resized/0004/9636/49636v1-max-150x150.png"],[[73,40],"assets/images/resized/0004/9636/49636v1-max-250x250.png"],[[73,40],"assets/images/resized/0004/9636/49636v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.thefreelibrary.com/Celladon+Secures+$30+Million+in+Series+B+Financing.-a0139513860","source_description":"Celladon Secures $30 Million in Series B Financing.","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":7,"company":{"name":"Celladon","permalink":"celladon","image":{"available_sizes":[[[150,19],"assets/images/resized/0006/4625/64625v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0006/4625/64625v1-max-250x250.jpg"],[[338,45],"assets/images/resized/0006/4625/64625v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":7080000,"raised_currency_code":"USD","funded_year":2005,"funded_month":9,"funded_day":16,"company":{"name":"DiObex","permalink":"diobex","image":{"available_sizes":[[[150,39],"assets/images/resized/0005/9950/59950v1-max-150x150.jpg"],[[163,43],"assets/images/resized/0005/9950/59950v1-max-250x250.jpg"],[[163,43],"assets/images/resized/0005/9950/59950v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://finance.yahoo.com/news/Arginetix-and-Immune-Control-bw-1922954142.html?x=0&.v=1","source_description":"Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Corridor Pharmaceuticals","permalink":"corridor-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/revision-optics-inc-series-d-35m/","source_description":"ReVision Optics, Inc.: Series D $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":20,"company":{"name":"ReVision Optics","permalink":"revision-optics","image":{"available_sizes":[[[150,74],"assets/images/resized/0009/4510/94510v2-max-150x150.jpg"],[[160,79],"assets/images/resized/0009/4510/94510v2-max-250x250.jpg"],[[160,79],"assets/images/resized/0009/4510/94510v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.otonomy.com/Otonomy-Series-B-Financing-(August-30-2010)-Final.pdf?item=10052","source_description":"Otonomy Closes $38.5 Million Series B Financing","raised_amount":38500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":30,"company":{"name":"Otonomy","permalink":"otonomy","image":{"available_sizes":[[[150,60],"assets/images/resized/0009/9975/99975v1-max-150x150.png"],[[232,94],"assets/images/resized/0009/9975/99975v1-max-250x250.png"],[[232,94],"assets/images/resized/0009/9975/99975v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.celatorpharma.com/new/pr_20100901.html","source_description":"CELATORÂ® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":1,"company":{"name":"Celator Pharmaceuticals","permalink":"celator-pharmaceuticals","image":{"available_sizes":[[[150,44],"assets/images/resized/0010/0352/100352v1-max-150x150.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-250x250.png"],[[242,72],"assets/images/resized/0010/0352/100352v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/eddingpharm-cayman-closes-24m-series-b.html","source_description":"Eddingpharm (Cayman) Closes $24M Series B Funding","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":17,"company":{"name":"Eddingpharm (Cayman)","permalink":"eddingpharm-cayman","image":{"available_sizes":[[[150,70],"assets/images/resized/0010/3680/103680v1-max-150x150.png"],[[177,83],"assets/images/resized/0010/3680/103680v1-max-250x250.png"],[[177,83],"assets/images/resized/0010/3680/103680v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.tobiratherapeutics.com/pdfs/Tobira_Therapeutics_Series.pdf","source_description":"Tobira Therapeutics Inc. Raises $31 Million in Series B Financing","raised_amount":31000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":29,"company":{"name":"Tobira Therapeutics","permalink":"tobira-therapeutics","image":{"available_sizes":[[[149,105],"assets/images/resized/0010/3787/103787v1-max-150x150.jpg"],[[149,105],"assets/images/resized/0010/3787/103787v1-max-250x250.jpg"],[[149,105],"assets/images/resized/0010/3787/103787v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.xconomy.com/san-francisco/2010/10/14/cell-biosciences-nabs-20m-buys-convergent/","source_description":"Cell Biosciences Nabs $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":14,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.atyrpharma.com/index.php?option=com_content&view=article&id=29:october-26th-2010&catid=1:current-press-releases&Itemid=20","source_description":"aTyr Pharma Secures $23M Financing From Top Tier Venture Investor","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":26,"company":{"name":"aTyr Pharma","permalink":"atyr-pharma","image":{"available_sizes":[[[150,128],"assets/images/resized/0006/0151/60151v1-max-150x150.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-250x250.png"],[[246,210],"assets/images/resized/0006/0151/60151v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.achillion.com/releasedetail.cfm?ReleaseID=500371","source_description":"Achillion Announces Private Placement of $50 Million","raised_amount":50100000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":18,"company":{"name":"Achillion Pharmaceuticals","permalink":"achillion-pharmaceuticals","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/0871/60871v2-max-150x150.png"],[[250,56],"assets/images/resized/0006/0871/60871v2-max-250x250.png"],[[303,69],"assets/images/resized/0006/0871/60871v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.zogenix.com/index.php/news/zogenix-secures-35-million-debt-facility-and-raises-15-million-investment-capital/","source_description":"Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":13,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.bizjournals.com/sanjose/stories/2010/08/09/daily62.html","source_description":"Nuon Therapeutics raises $10M in new funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":12,"company":{"name":"Nuon Therapeutics","permalink":"nuon-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/1236/51236v1-max-150x150.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-250x250.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.bizjournals.com/sanfrancisco/news/2011/02/04/integenx-raises-156m-buys-genvault.html","source_description":"IntegenX raises $15.6M, buys GenVault ","raised_amount":15600000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":4,"company":{"name":"IntegenX","permalink":"integenx","image":{"available_sizes":[[[150,43],"assets/images/resized/0012/0451/120451v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0012/0451/120451v1-max-250x250.jpg"],[[450,130],"assets/images/resized/0012/0451/120451v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://money.msn.com/business-news/article.aspx?feed=PR&Date=20110308&ID=13111899&topic=TOPIC_FINANCING&isub=1","source_description":"Astute Medical Completes $13 Million Financing With Existing Stockholders","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":8,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.bionanomatrix.com/upload/files/BioNanomatrix_Secures_233M.pdf","source_description":"BioNanomatrix Secures $23.3 Million in Series B Financing","raised_amount":23300000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":17,"company":{"name":"BioNano Genomics","permalink":"bionanomatrix","image":{"available_sizes":[[[150,23],"assets/images/resized/0006/2687/62687v1-max-150x150.png"],[[222,35],"assets/images/resized/0006/2687/62687v1-max-250x250.png"],[[222,35],"assets/images/resized/0006/2687/62687v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/102415/coda-therapeutics-inks-192m-series-b/","source_description":"CoDa Therapeutics Inks $19.2M Series B","raised_amount":19200000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":18,"company":{"name":"CoDa Therapeutics","permalink":"coda-therapeutics","image":{"available_sizes":[[[128,135],"assets/images/resized/0008/4437/84437v1-max-150x150.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-250x250.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.bizjournals.com/sanjose/news/2011/04/18/benvenue-medical-raises-355m.html","source_description":"Benvenue Medical raises $35.5M","raised_amount":35500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":18,"company":{"name":"Benvenue Medical","permalink":"benvenue-medical","image":{"available_sizes":[[[150,26],"assets/images/resized/0005/2834/52834v1-max-150x150.jpg"],[[250,44],"assets/images/resized/0005/2834/52834v1-max-250x250.jpg"],[[450,80],"assets/images/resized/0005/2834/52834v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.prnewswire.com/news-releases/colucid-pharmaceuticals-raises-75-million-of-planned-95-million-128664483.html","source_description":"CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":30,"company":{"name":"CoLucid Pharmaceuticals","permalink":"colucid-pharmaceuticals","image":{"available_sizes":[[[150,57],"assets/images/resized/0015/1961/151961v1-max-150x150.png"],[[210,81],"assets/images/resized/0015/1961/151961v1-max-250x250.png"],[[210,81],"assets/images/resized/0015/1961/151961v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.seraprognostics.com/2011/11/sera-secures-19-3-million-financing-appoints-greg-c-critchfield-md-as-chief-executive-officer/","source_description":"Sera Secures $19.3 million Financing; Appoints Greg C. Critchfield, MD as Chief Executive Officer","raised_amount":19300000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":15,"company":{"name":"Sera Prognostics","permalink":"sera-prognostics","image":{"available_sizes":[[[150,18],"assets/images/resized/0011/6245/116245v1-max-150x150.png"],[[250,31],"assets/images/resized/0011/6245/116245v1-max-250x250.png"],[[353,44],"assets/images/resized/0011/6245/116245v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/12/integenx-secures-40m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"IntegenX Secures $40M in Series C Funding","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":13,"company":{"name":"IntegenX","permalink":"integenx","image":{"available_sizes":[[[150,43],"assets/images/resized/0012/0451/120451v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0012/0451/120451v1-max-250x250.jpg"],[[450,130],"assets/images/resized/0012/0451/120451v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.ariadx.com/news/aria-corporate-press-release-1912.pdf","source_description":"Aria Diagnostics Secures $52.7 Million in Oversubscribed Series C Financing","raised_amount":52700000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":9,"company":{"name":"Aria Diagnostics","permalink":"aria-diagnostics","image":{"available_sizes":[[[150,86],"assets/images/resized/0016/9468/169468v1-max-150x150.png"],[[197,113],"assets/images/resized/0016/9468/169468v1-max-250x250.png"],[[197,113],"assets/images/resized/0016/9468/169468v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/01/carticept-medical-closes-10m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Carticept Medical Closes $10M Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":18,"company":{"name":"Carticept Medical","permalink":"carticept-medical","image":{"available_sizes":[[[150,53],"assets/images/resized/0007/9888/79888v1-max-150x150.jpg"],[[234,83],"assets/images/resized/0007/9888/79888v1-max-250x250.jpg"],[[234,83],"assets/images/resized/0007/9888/79888v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/apnex-medical-inc-series-c-20m/","source_description":"Apnex Medical, Inc.: Series C $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":15,"company":{"name":"Apnex Medical","permalink":"apnex-medical","image":{"available_sizes":[[[150,73],"assets/images/resized/0006/8533/68533v1-max-150x150.png"],[[226,111],"assets/images/resized/0006/8533/68533v1-max-250x250.png"],[[226,111],"assets/images/resized/0006/8533/68533v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.marketwatch.com/story/sequent-medical-announces-closing-of-260-million-venture-financing-2012-03-06","source_description":"Sequent Medical Announces Closing of $26.0 Million Venture Financing","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":6,"company":{"name":"Sequent Medical","permalink":"sequent-medical","image":{"available_sizes":[[[150,31],"assets/images/resized/0008/7118/87118v1-max-150x150.png"],[[250,53],"assets/images/resized/0008/7118/87118v1-max-250x250.png"],[[450,95],"assets/images/resized/0008/7118/87118v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120516e85grf516&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120516e85grf516%26from%3dalert%26pid%3d32","source_description":"Zyga Stacks Up $25M Series C To Test, Sell Joint Devices ","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":16,"company":{"name":"Zyga Technology","permalink":"zyga-technology","image":{"available_sizes":[[[150,27],"assets/images/resized/0019/0156/190156v1-max-150x150.png"],[[250,45],"assets/images/resized/0019/0156/190156v1-max-250x250.png"],[[430,79],"assets/images/resized/0019/0156/190156v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/05/kona-medical-raises-30m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Kona Medical Raises $30M in Series C Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":30,"company":{"name":"Kona Medical","permalink":"kona-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0019/3225/193225v1-max-150x150.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-250x250.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/astute-medical-completes-40-4m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Astute Medical Completes $40.4M Series C Financing","raised_amount":40400000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":7,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.sacbee.com/2012/06/28/4595560/benvenue-medical-secures-25-million.html#storylink=cpy","source_description":"Benvenue Medical Secures $25 Million Series D Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":28,"company":{"name":"Benvenue Medical","permalink":"benvenue-medical","image":{"available_sizes":[[[150,26],"assets/images/resized/0005/2834/52834v1-max-150x150.jpg"],[[250,44],"assets/images/resized/0005/2834/52834v1-max-250x250.jpg"],[[450,80],"assets/images/resized/0005/2834/52834v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120706e876sz65f&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120706e876sz65f%26from%3dalert%26pid%3d32","source_description":"BioNano Genomics Adds $10M to Series B ","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":6,"company":{"name":"BioNano Genomics","permalink":"bionanomatrix","image":{"available_sizes":[[[150,23],"assets/images/resized/0006/2687/62687v1-max-150x150.png"],[[222,35],"assets/images/resized/0006/2687/62687v1-max-250x250.png"],[[222,35],"assets/images/resized/0006/2687/62687v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/07/coda-therapeutics-raises-20m-closes-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CoDa Therapeutics Raises $20M in Second Closes Series B Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":24,"company":{"name":"CoDa Therapeutics","permalink":"coda-therapeutics","image":{"available_sizes":[[[128,135],"assets/images/resized/0008/4437/84437v1-max-150x150.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-250x250.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120906e896twqx2&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120906e896twqx2%26from%3dalert%26pid%3d32","source_description":"ROX Medical Grabs Another $6M for Hypertension Therapy","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":6,"company":{"name":"ROX Medical","permalink":"rox-medical","image":{"available_sizes":[[[139,52],"assets/images/resized/0021/0254/210254v1-max-150x150.jpg"],[[139,52],"assets/images/resized/0021/0254/210254v1-max-250x250.jpg"],[[139,52],"assets/images/resized/0021/0254/210254v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://sg.finance.yahoo.com/news/rightcare-solutions-raises-1-75m-200000945.html","source_description":"RightCare Solutions Raises $1.75M Series A Financing Round","raised_amount":1750000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":10,"company":{"name":"RightCare Solutions","permalink":"rightcare-solutions","image":{"available_sizes":[[[150,34],"assets/images/resized/0021/5165/215165v1-max-150x150.jpg"],[[250,57],"assets/images/resized/0021/5165/215165v1-max-250x250.jpg"],[[375,87],"assets/images/resized/0021/5165/215165v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/11/epic-sciences-completes-13m-series-equity-financing.html","source_description":"Epic Sciences Completes $13M Series B Equity Financing","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Epic Sciences","permalink":"epic-sciences","image":{"available_sizes":[[[150,31],"assets/images/resized/0022/0799/220799v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0022/0799/220799v1-max-250x250.jpg"],[[335,70],"assets/images/resized/0022/0799/220799v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.bizjournals.com/sanfrancisco/news/2012/12/04/kona-medical-raises-10m-in-series-c.html","source_description":"Kona Medical raises $10 million in new Series C funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":4,"company":{"name":"Kona Medical","permalink":"kona-medical","image":{"available_sizes":[[[150,41],"assets/images/resized/0019/3225/193225v1-max-150x150.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-250x250.jpg"],[[208,58],"assets/images/resized/0019/3225/193225v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Eighth Fund","funded_year":2009,"funded_month":4,"funded_day":8,"raised_amount":null,"raised_currency_code":"USD","source_url":"http://www.pehub.com/36503/domain-associates-raising-fund-viii/","source_description":"PeHub"}],"video_embeds":[],"external_links":[]}